Soledad Garcia de Vinuesa
Overview
Explore the profile of Soledad Garcia de Vinuesa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Quiroga B, Verdalles U, Reque J, de Vinuesa S, Goicoechea M, Luno J
Nefrologia
. 2013 Jul;
33(4):539-45.
PMID: 23897186
Introduction: Cardiovascular events (CV) are the major cause of mortality in chronic kidney disease patients (CKD). The aim of the present study was to determine the independent predictors of CV...
12.
Quiroga B, de Vinuesa S, Goicoechea M, Luno J
Nefrologia
. 2013 May;
33(3):428-9.
PMID: 23712233
No abstract available.
13.
Verdalles U, de Vinuesa S, Goicoechea M, Quiroga B, Reque J, Panizo N, et al.
Nephrol Dial Transplant
. 2012 Dec;
27 Suppl 4:iv31-5.
PMID: 23258808
Background: Expansion of extracellular volume (ECV) is a frequent cause of resistant hypertension (RHT) in patients with chronic kidney disease (CKD). The aim of this exploratory study was that of...
14.
Yuste C, de Vinuesa S, Goicoechea M, Barraca D, Panizo N, Quiroga B, et al.
Med Clin (Barc)
. 2012 Nov;
141(8):338-42.
PMID: 23182534
Background And Objective: Vitamin D (25-OH-D3) deficiency is an emerging global health problem. Chronic kidney disease (CKD) patients have a higher risk of this deficiency. We aimed to determine the...
15.
Arroyo D, Panizo N, de Vinuesa S, Goicoechea M, Verdalles U, Luno J
Nefrologia
. 2012 Sep;
32(5):655-8.
PMID: 23013952
Hypercalcemia is a potential adverse effect of calcium-containing ion exchange resins, often used in the treatment and prevention of hyperkalemia in chronic kidney disease (CKD). We describe a series of...
16.
Gutierrez E, Zamora I, Ballarin J, Arce Y, Jimenez S, Quereda C, et al.
J Am Soc Nephrol
. 2012 Sep;
23(10):1753-60.
PMID: 22956820
The long-term outcome of patients with IgA nephropathy who present with normal renal function, microscopic hematuria, and minimal or no proteinuria is not well described. Here, we studied 141 Caucasian...
17.
Fernandez Juarez G, Luno J, Barrio V, de Vinuesa S, Praga M, Goicoechea M, et al.
Am J Kidney Dis
. 2012 Sep;
61(2):211-8.
PMID: 22939518
Background: Blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers has been shown to lessen the rate of decrease in glomerular filtration rate in patients...
18.
Verdalles U, de Vinuesa S, Luno J
Nephrol Dial Transplant
. 2012 Jul;
27(9):3663.
PMID: 22805222
No abstract available.
19.
Goicoechea M, Quiroga B, de Vinuesa S, Verdalles U, Reque J, Panizo N, et al.
Ren Fail
. 2012 Jul;
34(8):1002-9.
PMID: 22746155
In chronic kidney disease (CKD) patients on dialysis, plasma interleukin (IL)-6 levels predict mortality better than other markers. Impact of intraindividual changes of inflammatory markers on cardiovascular (CV) events in...
20.
Quiroga B, Santos A, Verdalles U, Reque J, de Vinuesa S, Goicoechea M, et al.
Nefrologia
. 2012 Apr;
32(2):233-4.
PMID: 22466263
No abstract available.